Centiva Capital, LP Novartis Ag Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Novartis Ag stock. As of the latest transaction made, Centiva Capital, LP holds 2,263 shares of NVS stock, worth $219,692. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,263
Previous 4,361
48.11%
Holding current value
$219,692
Previous $464,000
43.97%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$786 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$678 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$560 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...